2. What is Syncope ?
Transient loss of conciousness (TLOC) attributable to global
cerebral hypoperfusion, characterized by
Rapid onset
Brevity
Spontaneous recovery
6. Patient Assessment
The initial evaluation should answer three key question .
Is this a true syncope ?
Has the aetiological diagnosis been determined?
Are there data suggestive a high risk of cardiovascular
events or death?
7. 1. Diagnosis of syncope
Was LOC complete ?
Was LOC transient with rapid onset and short duration ?
Did the patient recovery spontaneously, completely and
without sequelae?
Did the patient lose postural tone ?
8. 2. Aetiology diagnosis
Questions about circumstances just prior to attack
Position (supine, sitting , standing)
Activity (rest, change in posture, during or immediately after
exercise, during or immediately after urination, defecation
or swallowing)
Predisposing factors (crowded or warm place, prolonged
standing post-prandial period) and of precipitating events
(fear, intense pain, neck movements)
Questions about onset of the attack
Nausea, vomiting, feeling cold, sweating, pain in chest, pain
in neck, or shoulders,
9. Questions about attack (eye witness)
Skin color (pallor, cyanotic)
Duration of loss of consciousness
Movements ( tonic-clonic, etc.)
Tongue biting
Questions about the end of the attack
Nausea, vomiting, diaphoresis, feeling cold, muscle aches,
confusion, skin color, wounds
10. Questions about background
Number and duration of syncope spells
Family history of arrhythmic disease or sudden death
Presence of cardiac disease
Neurological disease (Parkinsons, epilepsy, narcolepsy)
Internal history (Diabetes)
Medications (Hypotensive, negative chronotropic and
antidepressant agents)
11. 3. Risk stratification
San Francisco Syncope Rule (SFSR)
C – congestive heart failure
H – Hematocrit < 30 %
E – ECG abnormal
S – shortness of breath
S – systolic < 90mmHg at triage
Sensitivity : 98%, specificity 56 %
Risk of serious outcome or death at 30 days
12. 3. Risk stratification
ROSE (Risk Stratification of Syncope in the Emergency
Department)
B - Brain natriuretic peptide level ≥ 300 pg per mL
- Bradycardia < 50 bpm
R – rectal examination ( fecal occult blood )
A – Anemia < 9g/L
C – Chest pain associated with syncope
E – ECG (Q wave not on lead III)
S – saturation < 94 % under RA
Sensitivity : 87%, specificity 66 %
Risk of serious outcome or death at 30 days
13. 3. Risk stratification
OESIL (Osservatorio Epidemiologico sulla Sincope nel Lazio)
Age > 65 years old
History of cardiovascular disease
Syncope without a prodrome
Abnormal ECG
risk of all-cause mortality at 12 months
14. High Risk category
AMI
Myocarditis
Dysrhythmias
Second and third degree heart
block
Pacemaker dysfunction
VT
Prolonged QT syndrome
Brugada syndrome
Ectopic pregnancy
Antepartum haemorrhage
Severe GI bleed
Pulmonary embolism
SAH
Actions :
1. Transfer patient to resus
2. Immediate resuscitation
3. Consider admission to ICU
4. Refer to relevant discipline stat .
15. Long QT syndrome
Bazett: 1920 QTc=QT/square root of the RR
Abnormal if QTc in males >470 ms and females of > 480 ms
Borderline prolonged QTc 450-470 ms
Average QTc for someone with the LQTS is 490 ms
16.
17. Causes of prolonged QT interval
Drugs : Antidysrhythmics (eg: quinidine, procainamide,
disopyramide, sotalol and amiodarone). Psychotropic agents
Electrolyte abnormalities : hypo K, Mg,Ca
Cardiac abnormalities : MI, Myocarditis
Intracranial Disease : SAH
Altered nutritional state : Liquid protein modified fast diet/
starvation
Congenital : Jervell and Lange- Nielsen syndrome , Romano-
Ward syndrome, Sporadic type
18. Diagnostic Criteria for LQTS
EKG findings
QTc
>480 3
460-470 2
450 (male) 1
Torsdade De Pointes 2
T-wave alternans 1
Notched T wave in 3 leads 1
Low heart rate for age 0.5
Clinical History
Syncope with stress 2
without stress 1
Congenital deafness 0.5
Family history
Definite LQTS 1
Unexplained SCD in immediate family member that is less than 30 years of age
0.5
19. <1 points low probability
2-3 points intermediate probability
>4 points high probability
21. Brugada syndrome diagnostic criteria
1. Type 1 ECG pattern in > 2 precordial leads (V1-V3), in
conjunction with one of the following :
Documented VF
Polymorphic VT
Family hx of sudden cardiac death < 45 yo
Coved type ECG in family member
Syncope
Nocturnal agonal respiration
Inducibility of VT with programmed electrial stimulation
2. Conversion of type 2/3 to type 1 after Sodium blocker
administration in conjuntion with above clinical features
22.
23. Moderate Risk category
Aortic stenosis
Hypertropic obstructive
cardiomyopathy (exertional
syncope)
Suspected mild CVA / TIA
Mild blood loss
Orthostatic syncope (volume loss)
Hypoglycemia
Patients with IHD
CCF
SVT
Drug induced syncope
Actions :
1. Stablilize the patient
2. Consider admitting the patient to observation unit.
24. Low Risk category
Vasovagal/neurocardiogenic
syncope eg :
Micturation/defaecation syncope
Postprandial
Tussive
Psychogenic syncope
Anxiety and panic disorder
Unexplained syncope
Actions :
1. Excluded all high risk and moderate risk condition
2. Observe > 2 hrs
3. Discharge if the patient is alert and attentive and parameters are stable
4. For patient with recurrent vasovagal syncope, consider referral to cardiology.
25. Actions :
1. Transfer patient to resus
2. Immediate resuscitation
3. Consider admission to ICU
4. Refer to relevant discipline stat .
26.
27. References
Shirley O, Sim TB. Syncope. Guide to The Essentials in
Emergency Medicine.
European Heart Journal (2009) Guideline for the diagnosis
and management of syncope.
Saklani et al. American Heart Association. Ciruculation
2013: syncope